These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 30334707)

  • 21. Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States.
    Richter SS; Diekema DJ; Heilmann KP; Dohrn CL; Riahi F; Doern GV
    Antimicrob Agents Chemother; 2014 Nov; 58(11):6484-9. PubMed ID: 25136018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased Carriage and Genetic Shifts in the Streptococcus pneumoniae Population After Changing the Seven-valent to the Thirteen-valent Pneumococcal Vaccine in Norway.
    Steens A; Caugant DA; Aaberge IS; Vestrheim DF
    Pediatr Infect Dis J; 2015 Aug; 34(8):875-83. PubMed ID: 26020410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
    Picazo JJ
    Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the pneumococcal conjugate vaccine on serotype distribution and susceptibility trends of pediatric non-invasive Streptococcus pneumoniae isolates in Tokai, Japan over a 5-year period.
    Okade H; Funatsu T; Eto M; Furuya Y; Mizunaga S; Nomura N; Mitsuyama J; Yamagishi Y; Mikamo H
    J Infect Chemother; 2014 Jul; 20(7):423-8. PubMed ID: 24802765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic diversity of pneumococcal surface protein A (PspA) in paediatric isolates of non-conjugate vaccine serotypes in Japan.
    Kawaguchiya M; Urushibara N; Aung MS; Morimoto S; Ito M; Kudo K; Kobayashi N
    J Med Microbiol; 2018 Aug; 67(8):1130-1138. PubMed ID: 29927374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.).
    Richter SS; Heilmann KP; Dohrn CL; Riahi F; Diekema DJ; Doern GV
    Emerg Infect Dis; 2013 Jul; 19(7):1074-83. PubMed ID: 23763847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016.
    Zhao C; Li Z; Zhang F; Zhang X; Ji P; Zeng J; Hu B; Hu Z; Liao K; Sun H; Zhang R; Cao B; Zhuo C; Jia W; Mei Y; Chu Y; Xu X; Yang Q; Jin Y; Fu Q; Xu X; Li H; Wang L; Ni Y; Liang H; Wang H
    BMC Infect Dis; 2017 Dec; 17(1):804. PubMed ID: 29284419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serotype distribution and susceptibility to penicillin and erythromycin among noninvasive or colonization isolates of Streptococcus pneumoniae in northern Japan: a cross-sectional study in the pre-PCV7 routine immunization period.
    Kawaguchiya M; Urushibara N; Ghosh S; Kuwahara O; Morimoto S; Ito M; Kudo K; Kobayashi N
    Microb Drug Resist; 2014 Oct; 20(5):456-65. PubMed ID: 24766085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of Streptococcus pneumoniae serotype 19A isolates from children in the pre and post Conjugate Vaccine Era. Single center experience 1986-2015.
    Koutouzis EI; Daikos GL; Chatzichristou P; Michos AG; Koutouzi FI; Chrousos GP; Syriopoulou VP
    Vaccine; 2018 Aug; 36(35):5245-5250. PubMed ID: 30061027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
    Techasaensiri C; Messina AF; Katz K; Ahmad N; Huang R; McCracken GH
    Pediatr Infect Dis J; 2010 Apr; 29(4):294-300. PubMed ID: 19949357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.
    Mokaddas E; Albert MJ
    Vaccine; 2012 Dec; 30 Suppl 6():G37-40. PubMed ID: 23228356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ; Klugman KP; Pichichero M
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predominance of Serogroup 19 CC320/271 among Penicillin-Nonsusceptible Streptococcus pneumoniae Isolates after Introduction of the PCV7 Vaccine in Several Regions of Japan.
    Oodate M; Kimura K; Banno H; Yokoyama S; Jin W; Wachino JI; Hasegawa Y; Arakawa Y
    Jpn J Infect Dis; 2018 Jan; 71(1):14-20. PubMed ID: 29093321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of the Seven-valent Pneumococcal Conjugate Vaccine on Acute Otitis Media in Japanese Children: Emergence of Serotype 15A Multidrug-resistant Streptococcus pneumoniae in Middle Ear Fluid Isolates.
    Ozawa D; Yano H; Endo S; Hidaka H; Kakuta R; Okitsu N; Kanamori H; Ogawa M; Ichimura S; Shimojima M; Inomata S; Kaku M; Katori Y
    Pediatr Infect Dis J; 2015 Sep; 34(9):e217-21. PubMed ID: 26083590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia.
    Desai AP; Sharma D; Crispell EK; Baughman W; Thomas S; Tunali A; Sherwood L; Zmitrovich A; Jerris R; Satola SW; Beall B; Moore MR; Jain S; Farley MM
    Pediatr Infect Dis J; 2015 Nov; 34(11):1168-74. PubMed ID: 26226445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic structures of invasive Streptococcus pneumoniae isolates from Korean children obtained between 1995 and 2013.
    Yun KW; Choi EH; Lee HJ; Kang JH; Kim KH; Kim DS; Kim YJ; Eun BW; Oh SH; Cho HK; Hong YJ; Kim KN; Kim NH; Kim YK; Lee H; Lee T; Kim HM; Cho EY; Kim CS; Park SE; Oh CE; Jo DS; Choi YY; Lee J
    BMC Infect Dis; 2018 Jun; 18(1):268. PubMed ID: 29884115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterization of penicillin non-susceptible Streptococcus pneumoniae isolated before and after pneumococcal conjugate vaccine implementation in Casablanca, Morocco.
    Diawara I; Barguigua A; Katfy K; Nayme K; Belabbes H; Timinouni M; Zerouali K; Elmdaghri N
    Ann Clin Microbiol Antimicrob; 2017 Apr; 16(1):23. PubMed ID: 28376809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia.
    Parra EL; De La Hoz F; Díaz PL; Sanabria O; Realpe ME; Moreno J
    Vaccine; 2013 Aug; 31(37):4033-8. PubMed ID: 23680440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid decrease of 7-valent conjugate vaccine coverage for invasive pneumococcal diseases in pediatric patients in Japan.
    Chiba N; Morozumi M; Shouji M; Wajima T; Iwata S; Sunakawa K; Ubukata K;
    Microb Drug Resist; 2013 Aug; 19(4):308-15. PubMed ID: 23480525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotype distribution and antimicrobial susceptibility pattern in children≤5years with invasive pneumococcal disease in India - A systematic review.
    Singh J; Sundaresan S; Manoharan A; Shet A
    Vaccine; 2017 Aug; 35(35 Pt B):4501-4509. PubMed ID: 28711387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.